Boothbay Fund Management, LLC Eli Lilly & CO Put Options Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $2.32 Million - $2.91 Million	3,200 New	3,200 $2.9 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $8.56 Million - $10.1 Million	16,300 New	16,300 $9.5 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $59,296 - $67,574	200 Added 14.29%	1,600 $517,000
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $613,206 - $719,994	-2,200 Reduced 61.11%	1,400 $454,000
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $844,884 - $1.05 Million	3,600 New	3,600 $1.03 Million

3,887

763M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.